secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0000950170-24-073749
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Olema annual meeting results: directors elected, compensation approved, auditor ratified
--------------------------------------------------------------------------------

- Ian Clark elected with 33,874,399 for; Sandra Horning 40,102,098 for; Gorjan Hrustanovic 44,334,757 for.
- Advisory say-on-pay vote approved: 45,174,223 for, 787,068 against, 8,069 abstain, 2,425,736 broker non-votes.
- Ratification of Ernst & Young as independent auditor for FY2024 passed: 48,366,695 for, 19,160 against, 9,241 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000095017024073749/0000950170-24-073749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000095017024073749/olma-20240613.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-073749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer